Integrating Bulk and Single-Cell Transcriptomics with Machine Learning Reveals a Heme Metabolism-Based Panel for Lung Adenocarcinoma Chemotherapy Resistance
International Journal of Molecular Sciences · 14.05.2025 · 26 (10) · 4685
DOI: 10.3390/ijms26104685 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.05.2025. Verfasst von Lin Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Surgery II, Peking University Cancer Hosp…. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Heme, Machine Learning, Adenocarcinoma of Lung. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Science and Technology Major Project of the Ministry of Science and Technology of China, National Key R&D Program of China.
Themen: Künstliche Intelligenz in der Pflege, Onkologische Pflege
Abstract (Originalsprache)
Lung adenocarcinoma (LUAD) is a leading cause of cancer-related mortality, with heme metabolism playing a critical role in tumor progression and treatment resistance. This study investigates the clinical implications of heme metabolism in LUAD, focusing on its link to ferroptosis and drug sensitivity. Using multi-omics data from TCGA-LUAD, GEO databases, and a single-cell RNA-seq cohort, we identified two molecular subtypes based on heme metabolism-related genes. We further developed a prognostic panel, termed the heme metabolism risk score (HMRS), using LASSO and multivariate Cox regression analyses. The HMRS panel effectively stratified patients into high- and low-risk groups, with high-risk patients showing enhanced tumor proliferation, suppressed ferroptosis, and resistance to chemotherapy. Single-cell analysis revealed elevated heme metabolism risk in epithelial cells correlated with tumor progression. Drug sensitivity predictions were validated in platinum-based chemotherapy cohorts, confirming HMRS as a robust prognostic tool. ABCC2 was identified as a key regulator of ferroptosis and cisplatin resistance, with in vitro experiments demonstrating that ABCC2 knockdown enhanced cisplatin-induced ferroptosis. These findings highlight HMRS as a critical tool for patient stratification and ABCC2 as a promising therapeutic target to overcome cisplatin resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Surgery II, Peking University Cancer Hospital & Institute, Beijing 100142, China.
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Clinical Laboratory, Peking University Cancer Hospital & Institute, Beijing 100142, China.
- State Key Laboratory of Molecular Oncology, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Thoracic Surgery II, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Förderung
- National Natural Science Foundation of China
- National Science and Technology Major Project of the Ministry of Science and Technology of China
- National Key R&D Program of China
- Capital's funds for health improvement and research
- Beijing Natural Science Foundation
- National Ten-thousand Talent Program, the Noncommunicable Chronic Diseases-National Sci-ence and Technology Major Project
- Foundation of China Association for Promotion of Health Science and Technology
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
Zitieren
APA
Zhao, L., Han, H., Zhou, X., Gong, T., Zhu, Y., Xiao, B., Liu, S., Zhao, W., & Wu, N. (2025). Integrating Bulk and Single-Cell Transcriptomics with Machine Learning Reveals a Heme Metabolism-Based Panel for Lung Adenocarcinoma Chemotherapy Resistance. International Journal of Molecular Sciences, 26(10), 4685. https://doi.org/10.3390/ijms26104685
Vancouver
Zhao L, Han H, Zhou X, Gong T, Zhu Y, Xiao B, et al. Integrating Bulk and Single-Cell Transcriptomics with Machine Learning Reveals a Heme Metabolism-Based Panel for Lung Adenocarcinoma Chemotherapy Resistance. International Journal of Molecular Sciences. 2025;26(10):4685. doi:10.3390/ijms26104685
BibTeX
@article{Zhao2025,
author = {Zhao, Lin and Han, Haibo and Zhou, Xuantong and Gong, Tongyang and Zhu, Yuge and Xiao, Bufan and Liu, Shuchang and Zhao, Wei and Wu, Nan},
title = {Integrating Bulk and Single-Cell Transcriptomics with Machine Learning Reveals a Heme Metabolism-Based Panel for Lung Adenocarcinoma Chemotherapy Resistance},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {10},
pages = {4685},
doi = {10.3390/ijms26104685}
}
EUVIMED